botensilimab and balstilimab in metastatic, pre-treated mss-crc
Published 1 year ago • 1.1K plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
4:49
botensilimab plus balstilimab for metastatic heavily pretreated mss colorectal cancer
-
1:22:29
contemporary management of metastatic colorectal cancer
-
1:29
com701 & nivolumab in patients with metastatic mss-crc & liver metastases
-
0:41
how can immunotherapies successfully target mss colorectal cancer?
-
0:46
key limitations of current treatment options for patients with mss-crc
-
0:47
the emerging role of immunotherapy for microsatellite stable colorectal cancer
-
6:56
prior rt may potentially enhance treatment of mss-crc with regorafenib and pembrolizumab
-
2:23
swog s2107: encorafenib, cetuximab ± nivolumab in previously treated, mss, brafv600e crc
-
1:40
novel combination immunotherapy for patients with metastatic colorectal cancer
-
1:26
rare breakthrough in advanced colorectal cancer treatment
-
1:04
phase ii trial of nivolumab and relatlimab in mss crc
-
2:06
highlights in gi cancers from sitc 2022
-
1:55
the latest in targeted therapies for advanced colorectal cancer
-
0:43
onilon: trifluridine/tipiracil with nanoliposomal irinotecan in advanced crc
-
0:24
how can we incorporate checkpoint inhibition in microsatellite stable colorectal cancer?
-
3:59
the selection of pd-l1 escape variants in microsatellite stable metastatic crc on avelumab treatment
-
4:11
personalized, neoantigen-directed immunotherapy in patients with advanced mss-crc, gea and nsclc
-
0:06
signs and symptoms of colorectal cancer
-
4:19
targeting braf in metastatic crc